Jeong Y, Li W, Yang H, Choi J, Oh Y
Nutrients. 2024; 16(19).
PMID: 39408233
PMC: 11478629.
DOI: 10.3390/nu16193266.
Wang Q, Yang Y, Chen Z, Li B, Niu Y, Li X
Pharmaceutics. 2024; 16(5).
PMID: 38794327
PMC: 11124897.
DOI: 10.3390/pharmaceutics16050666.
Zhao L, Miao Y, Shan B, Zhao C, Peng C, Gong J
Foods. 2023; 12(7).
PMID: 37048289
PMC: 10094067.
DOI: 10.3390/foods12071468.
Li Z, Yin Z, Li B, He J, Liu Y, Zhang N
Int J Mol Sci. 2023; 24(3).
PMID: 36768193
PMC: 9915434.
DOI: 10.3390/ijms24031872.
Liu J, Zhang H, Su Y, Zhang B
Cell Biosci. 2022; 12(1):68.
PMID: 35619184
PMC: 9134593.
DOI: 10.1186/s13578-022-00810-w.
Effects of substituting soybean meal with corn on immune function and gene expression of gut TLR4 pathway of growing goats.
Cheng Y, Yang C, Chen W, Yan Q, Tan Z, He Z
PeerJ. 2022; 10:e12910.
PMID: 35186490
PMC: 8830315.
DOI: 10.7717/peerj.12910.
Impaired Innate Immunity in Pediatric Patients Type 1 Diabetes-Focus on Toll-like Receptors Expression.
Kurianowicz K, Klatka M, Polak A, Hymos A, Bebnowska D, Podgajna M
Int J Mol Sci. 2021; 22(22).
PMID: 34830017
PMC: 8625857.
DOI: 10.3390/ijms222212135.
T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells.
Nouri Y, Weinkove R, Perret R
J Immunother Cancer. 2021; 9(11).
PMID: 34799397
PMC: 8606765.
DOI: 10.1136/jitc-2021-003065.
TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymanska A, Bojarska-Junak A, Drobiecki A, Tomczak W, Rolinski J, Hus M
Arch Immunol Ther Exp (Warsz). 2018; 67(1):55-65.
PMID: 30196472
PMC: 6433797.
DOI: 10.1007/s00005-018-0523-9.
Ts-Hsp70 induces protective immunity against Trichinella spiralis infection in mouse by activating dendritic cells through TLR2 and TLR4.
Zhang R, Sun Q, Chen Y, Sun X, Gu Y, Zhao Z
PLoS Negl Trop Dis. 2018; 12(5):e0006502.
PMID: 29775453
PMC: 5979045.
DOI: 10.1371/journal.pntd.0006502.
U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue diseasePart II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease.
Paradowska-Gorycka A
Reumatologia. 2016; 53(3):143-51.
PMID: 27407241
PMC: 4847297.
DOI: 10.5114/reum.2015.53136.
Expression of toll-like receptors 2 and 4 in subjects with asthma by total serum IgE level.
Crespo-Lessmann A, Mateus E, Vidal S, Ramos-Barbon D, Torrejon M, Giner J
Respir Res. 2016; 17:41.
PMID: 27084682
PMC: 4833957.
DOI: 10.1186/s12931-016-0355-2.
Role of innate immunity in the development of hepatocellular carcinoma.
Aravalli R
World J Gastroenterol. 2013; 19(43):7500-14.
PMID: 24282342
PMC: 3837249.
DOI: 10.3748/wjg.v19.i43.7500.
Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's Toxin.
Maletzki C, Klier U, Obst W, Kreikemeyer B, Linnebacher M
Clin Dev Immunol. 2012; 2012:230625.
PMID: 23193416
PMC: 3502841.
DOI: 10.1155/2012/230625.
Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.
Pei J, Ding X, Fan Y, Rice-Ficht A, Ficht T
Front Cell Infect Microbiol. 2012; 2:115.
PMID: 22973560
PMC: 3435510.
DOI: 10.3389/fcimb.2012.00115.
Toll-like receptors in secondary obstructive cholangiopathy.
Miranda-Diaz A, Alonso-Martinez H, Hernandez-Ojeda J, Arias-Carvajal O, Rodriguez-Carrizalez A, Roman-Pintos L
Gastroenterol Res Pract. 2011; 2011:265093.
PMID: 22114589
PMC: 3205723.
DOI: 10.1155/2011/265093.
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
Cheng C, Jain P, Bettahi I, Pal S, Tifrea D, de la Maza L
Vaccine. 2011; 29(38):6641-9.
PMID: 21742006
PMC: 3156873.
DOI: 10.1016/j.vaccine.2011.06.105.
Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation.
Ito T, Schaller M, Raymond T, Joshi A, Coelho A, Frantz F
Am J Respir Crit Care Med. 2009; 180(12):1227-38.
PMID: 19797157
PMC: 2796734.
DOI: 10.1164/rccm.200906-0892OC.
[Role of toll-like receptors in respiratory diseases].
Crespo-Lessmann A, Juarez-Rubio C, Plaza-Moral V
Arch Bronconeumol. 2009; 46(3):135-42.
PMID: 19765883
PMC: 7129367.
DOI: 10.1016/j.arbres.2009.07.011.
Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.
Cheng C, Bettahi I, Cruz-Fisher M, Pal S, Jain P, Jia Z
Vaccine. 2009; 27(44):6239-46.
PMID: 19686693
PMC: 3566636.
DOI: 10.1016/j.vaccine.2009.07.108.